STAAR Surgical Revenue 2010-2023 | STAA

STAAR Surgical revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
STAAR Surgical Annual Revenue
(Millions of US $)
2023 $322
2022 $284
2021 $230
2020 $163
2019 $150
2018 $124
2017 $91
2016 $82
2015 $77
2014 $75
2013 $72
2012 $64
2011 $63
2010 $55
2009 $51
STAAR Surgical Quarterly Revenue
(Millions of US $)
2023-12-31 $76
2023-09-30 $80
2023-06-30 $92
2023-03-31 $74
2022-12-31 $64
2022-09-30 $76
2022-06-30 $81
2022-03-31 $63
2021-12-31 $59
2021-09-30 $58
2021-06-30 $62
2021-03-31 $51
2020-12-31 $46
2020-09-30 $47
2020-06-30 $35
2020-03-31 $35
2019-12-31 $39
2019-09-30 $39
2019-06-30 $40
2019-03-31 $33
2018-12-31 $31
2018-09-30 $32
2018-06-30 $34
2018-03-31 $27
2017-12-31 $25
2017-09-30 $23
2017-06-30 $22
2017-03-31 $20
2016-12-31 $22
2016-09-30 $20
2016-06-30 $21
2016-03-31 $19
2015-12-31 $21
2015-09-30 $19
2015-06-30 $19
2015-03-31 $19
2014-12-31 $17
2014-09-30 $18
2014-06-30 $20
2014-03-31 $20
2013-12-31 $19
2013-09-30 $17
2013-06-30 $18
2013-03-31 $18
2012-12-31 $16
2012-09-30 $16
2012-06-30 $16
2012-03-31 $16
2011-12-31 $16
2011-09-30 $15
2011-06-30 $16
2011-03-31 $15
2010-12-31 $14
2010-09-30 $13
2010-06-30 $14
2010-03-31 $14
2009-12-31 $13
2009-09-30 $12
2009-06-30 $13
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.275B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
West Pharmaceutical Services (WST) United States $27.478B 46.45
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
Henry Schein (HSIC) United States $9.256B 16.01
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
CONMED (CNMD) United States $2.236B 21.05
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72
Biolase (BIOL) United States $0.005B 0.00